|
|
Volumn 9, Issue 3, 2009, Pages 250-251
|
|
Current Cancer Drug Targets: Editorial
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CAVEOLIN 1;
CISPLATIN;
CYTOTOXIC AGENT;
DAUNORUBICIN;
GLYCOPROTEIN P;
LAPATINIB;
MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR;
MUSTARD GAS;
PACLITAXEL;
PROTEIN KINASE INHIBITOR;
TRASTUZUMAB;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
BREAST TUMOR;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER RESEARCH;
CANCER RESISTANCE;
CANCER SURGERY;
DRUG MECHANISM;
DRUG RESEARCH;
DRUG RESPONSE;
DRUG SENSITIVITY;
EDITORIAL;
HUMAN;
LEUKEMIA;
LEUKOPENIA;
LYMPHOMA;
MEDICAL LITERATURE;
METASTASIS;
MULTIDRUG RESISTANCE;
PHOTODYNAMIC THERAPY;
SEMINOMA;
TREATMENT RESPONSE;
DRUG RESISTANCE;
GENETICS;
NEOPLASM;
PHENOTYPE;
ANTINEOPLASTIC AGENTS;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
LEUKEMIA;
LYMPHOMA;
NEOPLASMS;
PHENOTYPE;
|
|
EID: 65649142533
PISSN: 15680096
EISSN: None
Source Type: Journal
DOI: 10.2174/156800909788166510 Document Type: Editorial |
|
Times cited : (9)
|
|
References (0)
|
